Creating and Sustaining Successful Pharma & Biotech Alliance Teams

Alliances in the pharma and biotech industries are on the rise, growing over 80% over the last 10 years. The problem is that as many as 60% to 70% of these alliances underperform or even fail. Yet despite such past performance, most companies expect to continue to form strategic alliances. If alliances remain an inevitable part of corporate strategy, pharma and biotech companies must learn how to create and sustain successful alliances.

Drawing on experience working with such companies as Pfizer, Biogen Idec, Boehringer Ingelheim, and P&G Pharmaceuticals and their alliance teams, Lynda McDermott provides conference attendees with insight into the best practices and relevant tools for launching and developing successful alliance teams.

Creating and Sustaining Successful Pharma & Biotech Alliance Teams is being presented by Lynda McDermott, President, with EquiPro International and airs on Wednesday, May 27, 2009. For more details or to register, please visit our site at www.fxconferences.com

Global Regulatory Teamwork Strategies

Are you in the process of putting together a team to take your products or services global? Unsure where to begin? Global teams have become the norm in the life sciences industries. When they work well, these teams can bring new products to markets all around the world in record time. But when they don't work well, global teams can end up operating as a collection of national sub-teams that ignore or even compete with one another.

How do you build effective, cohesive global teams in the device, diagnostics or pharmaceutical industries, while avoiding the costly mistakes that can lead to dysfunction -- or worse! Join us and get the answers you need!

Global Regulatory Teamwork Strategies was presented by Dr. Lionel Laroche, Executive Vice President, with CPI Hazell & Associates and is available for download at www.fxconferences.com